David Humphrey
2022
In 2022, David Humphrey earned a total compensation of $780.6K as Chief Financial Officer at Ensysce Biosciences, a 175% increase compared to previous year.
Compensation breakdown
| Option Awards | $438,562 |
|---|---|
| Salary | $328,333 |
| Other | $13,722 |
| Total | $780,617 |
Humphrey received $438.6K in option awards, accounting for 56% of the total pay in 2022.
Humphrey also received $328.3K in salary and $13.7K in other compensation.
Rankings
In 2022, David Humphrey's compensation ranked 3,544th out of 5,717 executives tracked by ExecPay. In other words, Humphrey earned more than 38.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,544 out of 5,717 | 38th |
Division Manufacturing | 2,011 out of 3,111 | 35th |
Major group Chemicals And Allied Products | 958 out of 1,410 | 32nd |
Industry group Drugs | 896 out of 1,311 | 32nd |
Industry Pharmaceutical Preparations | 651 out of 957 | 32nd |
Source: SEC filing on July 13, 2023.
Humphrey's colleagues
We found three more compensation records of executives who worked with David Humphrey at Ensysce Biosciences in 2022.